These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 23696114

  • 21. Hyponatremia in cirrhosis: Risk factors and prognostic value.
    Ennaifer R, Cheikh M, Romdhane H, El Elj R, Ben Nejma H, Bougassas W, Bel Hadj N.
    Tunis Med; 2016 May; 94(5):401-405. PubMed ID: 27801493
    [Abstract] [Full Text] [Related]

  • 22. Terlipressin therapy for renal failure in cirrhosis.
    Triantos CK, Samonakis D, Thalheimer U, Cholongitas E, Senzolo M, Marelli L, Leandro G, Patch D, Burroughs AK.
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
    [Abstract] [Full Text] [Related]

  • 23. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G.
    Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
    [Abstract] [Full Text] [Related]

  • 24. The hepatorenal syndrome in liver transplant recipients.
    Seu P, Wilkinson AH, Shaked A, Busuttil RW.
    Am Surg; 1991 Dec; 57(12):806-9. PubMed ID: 1746799
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic significance of nitrates and nitrites and L-arginine, in development of hepatorenal syndrome in patients with end stage alcoholic liver cirrhosis.
    Nickovic V, Kocic G, Bjelakovic G, Pavlovic R, Stojanovic I, Katanic R, Stojanovic S, Djindjic B.
    Ren Fail; 2013 Dec; 35(5):633-9. PubMed ID: 23651488
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee JY, Lee SD.
    Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
    [Abstract] [Full Text] [Related]

  • 27. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival.
    Barreto R, Fagundes C, Guevara M, Solà E, Pereira G, Rodríguez E, Graupera I, Martín-Llahí M, Ariza X, Cárdenas A, Fernández J, Rodés J, Arroyo V, Ginès P.
    Hepatology; 2014 Apr; 59(4):1505-13. PubMed ID: 24037970
    [Abstract] [Full Text] [Related]

  • 28. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center.
    Watt K, Uhanova J, Minuk GY.
    Am J Gastroenterol; 2002 Aug; 97(8):2046-50. PubMed ID: 12190175
    [Abstract] [Full Text] [Related]

  • 29. [Hepatorenal syndrome].
    Pŭrvanov P.
    Khirurgiia (Sofiia); 2002 Aug; 58(2):34-9. PubMed ID: 12515019
    [Abstract] [Full Text] [Related]

  • 30. Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation.
    Bachmann-Brandt S, Bittner I, Neuhaus P, Frei U, Schindler R.
    Transpl Int; 2000 Aug; 13(5):357-62. PubMed ID: 11052272
    [Abstract] [Full Text] [Related]

  • 31. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [Abstract] [Full Text] [Related]

  • 32. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 33. Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis.
    Appenrodt B, Zielinski J, Brensing KA, Heller J, Sauerbruch T, Schepke M.
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1428-32. PubMed ID: 19794309
    [Abstract] [Full Text] [Related]

  • 34. Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis.
    Nicković V, Nikolić J, Djindjić N, Ilić M, Nicković J, Mladenović D, Krstić N.
    Vojnosanit Pregl; 2012 Aug; 69(8):686-91. PubMed ID: 22924265
    [Abstract] [Full Text] [Related]

  • 35. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 36. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y.
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [Abstract] [Full Text] [Related]

  • 37. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 38. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
    Sagi SV, Mittal S, Kasturi KS, Sood GK.
    J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
    [Abstract] [Full Text] [Related]

  • 39. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice.
    Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P, Italian Association of the Hospital Gastroenterologists (AIGO) investigators.
    J Hepatol; 2011 Dec; 55(6):1241-8. PubMed ID: 21703199
    [Abstract] [Full Text] [Related]

  • 40. Is there any potential or additive effect of anemia on hepatorenal syndrome?
    Güngör G, Akyıldız M, Keskin M, Solak Y, Gaipov A, Bıyık M, Çifçi S, Ataseven H, Polat H, Demir A.
    Turk J Gastroenterol; 2016 May; 27(3):273-8. PubMed ID: 27210785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.